4D Molecular Therapeutics, Inc. (FDMT) › Shares Outstanding4D Molecular Therapeutics, Inc. (FDMT) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2019: 5.18M2020: 26.68M2021: 32.22M2022: 32.63M2023: 43.08M2024: 45.79M2025: 57.61M57.61M2019Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202557.61M+25.8%202445.79M+6.3%202343.08M+32.0%202232.63M+1.2%202132.22M+20.8%202026.68M+415.2%20195.18M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share